文献速递中医妇科中药与中成药合理使用

桂枝茯苓胶囊通过促进p62-Keap1-NRF2介导的铁死亡改善子宫内膜增生

Guizhi Fuling Capsule ameliorates endometrial hyperplasia through promoting p62-Keap1-NRF2-mediated ferroptosis.
PubMed 文献 · J Ethnopharmacol · 2021-03-24

本研究在小鼠中评估桂枝茯苓胶囊(GFC)抗子宫内膜增生的作用及机制。采用雌二醇诱导C57BL/6小鼠子宫内膜增生模型,GFC(75 mg/kg和150 mg/kg)灌胃给药。结果提示GFC可能通过抑制p62-Keap1-NRF2通路触发铁死亡而减轻子宫内膜增生。

要点

  • 子宫内膜增生患者内膜组织铁死亡程度低于正常内膜组织。
  • 铁死亡诱导剂咪唑酮埃拉斯汀可改善小鼠子宫内膜增生。
  • GFC可能通过抑制p62-Keap1-NRF2通路触发铁死亡来减轻小鼠子宫内膜增生。

核心结论

  • GFC可能通过抑制p62-Keap1-NRF2通路触发铁死亡,从而减轻雌二醇诱导的小鼠子宫内膜增生。

研究设计与样本

  • 研究采用雌二醇诱导的C57BL/6小鼠子宫内膜增生模型。
  • 小鼠皮下注射雌二醇21天,自造模第1天起灌胃GFC 75 mg/kg和150 mg/kg。

主要发现

  • 子宫内膜增生患者内膜组织铁死亡程度低于正常子宫内膜组织。
  • 铁死亡诱导剂咪唑酮埃拉斯汀可改善小鼠子宫内膜增生。
  • GFC显著减轻小鼠子宫内膜增生并触发铁死亡。
  • GFC抑制雌二醇诱导的子宫内膜增生模型中的p62-Keap1-NRF2通路。

临床怎么用

  • 原文提示GFC可能作为治疗子宫内膜增生的潜在中药,但临床用药需结合患者具体情况审慎评估。

局限性

  • 研究仅在小鼠模型中开展,尚未提供临床人体研究证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Guizhi Fuling Capsule (GFC) is a classical traditional Chinese medicine officially recorded in Synopsis of the Golden Chamber and has long been used to treat gynecological diseases in China. However, scientific evidence for the anti-endometrial hyperplasia potential of GFC used in traditional medicine is lacking. AIM OF THE STUDY: This study evaluated whether GFC protects against endometrial hyperplasia and its potential mechanism in mice. METHODS AND MATERIALS: We used estrogen (estradiol) to induce endometrial hyperplasia in mice. C57BL/6 mice were treated with estradiol subcutaneously for 21 days, and GFC (75 mg/kg and 150 mg/kg) was given intragastric administration from the first day of the modeling. H&E staining is used to evaluate endometrial tissue structure change. Malondialdehyde was measured to explore lipid peroxidation. Western blot, immunohistochemistry and immunofluorescence were performed to observe the expressions of GPX4, p62, Keap1 and NRF2. RESULTS: The degree of ferroptosis in endometrial tissue of patients with endometrial hyperplasia was lower than normal endometrial tissue. In addition, ferroptosis inducer imidazole ketone erastin could improve endometrial hyperplasia in mice. Interestingly, GFC significantly alleviated endometrial hyperplasia through triggering ferroptosis. Furthermore, GFC inhibited p62-Keap1-NRF2 pathway in estradiol-induced endometrial hyperplasia model. CONCLUSIONS: GFC may attenuate estrogen-induced endometrial hyperplasia in mice through triggering ferroptosis via inhibiting p62-Keap1-NRF2 pathway. These findings suggest that GFC might act as a promising traditional Chinese medicine to treat endometrial hyperplasia.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Zhang M, Zhang T, Song C, et al. Guizhi Fuling Capsule ameliorates endometrial hyperplasia through promoting p62-Keap1-NRF2-mediated ferroptosis. J Ethnopharmacol. 2021. PMID: 33771639. doi:10.1016/j.jep.2021.114064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。